Topic Review
Dapagliflozin and Heart Failure
Heart failure (HF) is associated with a high morbidity and mortality burden. In light of more recent evidence, SGLT2 inhibitors are currently recommended as first-line therapy in managing patients with HF, regardless of ejection fraction, to reduce HF burden. The DAPA-HF and DELIVER trials, and particularly, the pooled analysis of both studies, have shown that dapagliflozin significantly reduces the risk of cardiovascular death, all-cause death, total HF hospitalizations, and MACE in the whole spectrum of HF, with sustained benefits over time.
  • 248
  • 07 Nov 2023
Topic Review
Hemorrhagic Transformation of Ischemic Strokes
Ischemic stroke (IS), resulting from insufficient blood supply to the brain, is among the leading causes of death and disability worldwide. A potentially severe complication of the disease itself or its treatment aiming to restore optimal blood flow is hemorrhagic transformation (HT) increasing morbidity and mortality.
  • 300
  • 07 Nov 2023
Topic Review
Retinal Prostheses
A retinal prosthesis, also known as a bionic eye, is a device that can be implanted to partially restore vision in patients with retinal diseases that have resulted in the loss of photoreceptors (e.g., age-related macular degeneration and retinitis pigmentosa). There have been major breakthroughs in retinal prosthesis technology, with the creation of numerous types of implants, including epiretinal, subretinal, and suprachoroidal sensors. These devices can stimulate the remaining cells in the retina with electric signals to create a visual sensation.
  • 319
  • 07 Nov 2023
Topic Review
GPER in Metastasis and Tumoral Microenvironments
Estrogens and their role in cancer are well-studied, and some cancer types are classified in terms of their response to them. A G protein-coupled estrogen receptor (GPER) has been described with relevance in cancer. GPER is a pleiotropic receptor with tissue-specific activity; in normal tissues, its activation is related to correct development and homeostasis, while in cancer cells, it can be pro- or anti-tumorigenic. Also, GPER replaces estrogen responsiveness in estrogen receptor alpha (ERα)-lacking cancer cell lines. One of the most outstanding activities of GPER is its role in epithelial–mesenchymal transition (EMT), which is relevant for metastasis development. In addition, the presence of this receptor in tumor microenvironment cells contributes to the phenotypic plasticity required for the dissemination and maintenance of tumors. These characteristics suggest that GPER could be a promising therapeutic target for regulating cancer development. 
  • 307
  • 07 Nov 2023
Topic Review
Omega-3 Lipid Mediators in Chronic Liver Diseases
Omega-3s are found in three main forms, namely, α-linolenic acid (ALA, 18C:3 n-3), eicosapentaenoic acid (EPA, 20C:5 n-3), and docosahexaenoic acid (DHA, 22C:6 n-3).
  • 332
  • 07 Nov 2023
Topic Review
Vasopressin in Sepsis and Other Shock States
Septic shock is defined by the need for vasopressors to correct hypotension and lactic acidosis secondary to infection, with a high mortality rate. The Surviving Sepsis Campaign guidelines recommend vasopressin as a second-line vasopressor, added to norepinephrine. 
  • 376
  • 07 Nov 2023
Topic Review
Activity-Based Therapies in Stroke Neurorehabilitation
Activity-based therapies are the key component of stroke neurorehabilitation. The principle of these therapies is to provide structuralized activities with adequate quantity and quality to induce plasticity for recovery. However, there are many challenges in clinical and research settings, including a lack of standardization, limited dose and intensity, and variability of responders. While the therapies with favorable plasticity use high intensity in animal studies with a range of 300–800 repetitions, achieving similar intensity in clinical settings has been challenging. 
  • 193
  • 07 Nov 2023
Topic Review
Complex Pharmacological Properties of Non-Selective Opioid Modulator Buprenorphine
Buprenorphine has high affinity for the mu-opioid receptor (MOR), delta (DOR), and kappa (KOR) and intermediate affinity for the nociceptin (NOR). Buprenorphine’s active metabolite, norbuprenorphine, crosses the blood–brain barrier, is a potent metabolite that attenuates the analgesic effects of buprenorphine due to binding to NOR, and is responsible for the respiratory depressant effects. The area under the concentration curves are very similar for buprenorphine and norbuprenorphine, which indicates that it is important to consider this metabolite. 
  • 332
  • 07 Nov 2023
Topic Review
Cellular Neurobiology of Psychedelics
Psychedelic substances have gained significant attention in recent years for their potential therapeutic effects on various psychiatric disorders.
  • 453
  • 07 Nov 2023
Topic Review
Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains
Staphylococcus aureus (S. aureus) is a common pathogen involved in community- and hospital-acquired infections. Its biofilm formation ability predisposes it to device-related infections. Methicillin-resistant S. aureus (MRSA) strains are associated with more serious infections and higher mortality rates and are more complex in terms of antibiotic resistance.
  • 212
  • 07 Nov 2023
  • Page
  • of
  • 1349
Video Production Service